NeuroPace, Inc.(NPCE)Earnings, Financials & Key RatiosNeuroPace, Inc. (NPCE) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to generate positive free cash flow, evidenced by a -27.3% FCF margin in 2026Q1, suggests a high risk of continued capital base erosion.
NeuroPace, Inc. (NPCE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
NeuroPace, Inc. (NPCE) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.13vs $0.19+31.6% | $22Mvs $22M+1.6% |
| Q2 2026 | Mar 3, 2026 | $0.08vs $0.14+42.9% | $27Mvs $25M+7.4% |
| Q4 2025 | Nov 4, 2025 | $0.11vs $0.20+45.0% | $27Mvs $25M+9.3% |
| Q3 2025 | Aug 12, 2025 | $0.26vs $0.24-8.3% | $24Mvs $24M-3.7% |
Recent stock market news and headlines for NeuroPace, Inc. (NPCE)
The mean of analysts' price targets for NeuroPace (NPCE) points to a 27.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Key metrics vs top competitors for NeuroPace, Inc. (NPCE)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $15.77 | $537.66M | -23.89 | 25.13% | -21.47% | -158.74% | — | |
| $82.48 | $4.53B | -18.53 | 10.74% | 7.47% | 9.13% | — | |
| $44.07 | $364.9M | 51.24 | 16.97% | 14.08% | 22.14% | — | |
| $79.20 | $101.68B | 21.23 | 8.43% | 13.2% | 9.78% | — | |
| $92.16 | $160.53B | 24.77 | 5.67% | 13.91% | 12.09% | — | |
| $43.06 | $64B | 22.20 | 19.87% | 17.23% | 14.67% | — |
NeuroPace, Inc. (NPCE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NeuroPace, Inc. (NPCE) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 12, 2026·SEC
Mar 3, 2026·SEC
Nov 4, 2025·SEC
Get notified when NPCE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NeuroPace, Inc. (NPCE) stock FAQ — growth, dividends, profitability & financials explained
NeuroPace, Inc. (NPCE) reported $99.5M in revenue for fiscal year 2025. This represents a 169% increase from $37.0M in 2019.
NeuroPace, Inc. (NPCE) grew revenue by 25.1% over the past year. This is strong growth.
NeuroPace, Inc. (NPCE) reported a net loss of $21.6M for fiscal year 2025.
NeuroPace, Inc. (NPCE) has a return on equity (ROE) of -158.7%. Negative ROE indicates the company is unprofitable.
NeuroPace, Inc. (NPCE) had negative free cash flow of $9.8M in fiscal year 2025, likely due to heavy capital investments.
